Independent Director · SUTRO BIOPHARMA, INC. (STRO)

Chair, Audit Committee

Sukhi Jagpal director compensation at Sutro Biopharma (FY2025): $99.3K

Fiscal year 2025 director compensation for Sukhi Jagpal at SUTRO BIOPHARMA, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 22, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Sukhi Jagpal’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Sukhi Jagpal and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

SUTRO BIOPHARMA Director Compensation Table · all 2 fiscal years held
In US dollars, as SUTRO BIOPHARMA reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$57,500$0$41,795$0$99,295
FY2024$19,647—$179,725—$199,372

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SUTRO BIOPHARMA, INC. DEF 14A filed April 22, 2026, accession 0001193125-26-170354, and prior-year filings. Open the filing on EDGAR.

How this page was built: the SUTRO BIOPHARMA, INC. filed document, accession 0001193125-26-170354. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.

Get the SUTRO BIOPHARMA Board Governance Report

$99,295 Sukhi Jagpal, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 22, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

SUTRO BIOPHARMA pays directors a $40,000 cash retainer and $41,795 in equity.

Committees

FY2025 · as the proxy prints them

Audit (Chair)

The rest of the SUTRO BIOPHARMA board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Connie MatsuiIndependent Director$121,795
Daniel H. PetreeIndependent Director$95,295
Heidi HunterIndependent Director$99,295
James PanekIndependent Director$96,795
Jane Chung, R.PhDirector—
Jon Wigginton, M.DIndependent Director$100,295
Joseph M. LobackiIndependent Director$108,795
Michael Dybbs, Ph.DIndependent Director$86,795

The full SUTRO BIOPHARMA compensation record

free company brief

This page is one director within SUTRO BIOPHARMA's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the SUTRO BIOPHARMA proxy · each links to its own free brief

Order STRO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report